Philips says it has completed actionable registrations across sleep therapy and ventilator devices and is closing the U.S. Patient Portal related to its recall as of Jan. 1, 2026.
Nearly five years after the Philips Respironics recall reshaped the CPAP market, respondents to a recent HME Newspoll say ...
ResMed (NYSE:RMD) is seeing growing use of wearable devices for sleep apnea pre screening, widening its reach before patients ever enter a sleep lab. Recent FDA approvals are supporting ResMed's role ...
Sept 24 (Reuters) - (This Sept.24 story has been refiled to remove a picture, with no changes to text) Investor group European Investors-VEB on Wednesday applied for a court inquiry into Philips ...
Medical device manufacturer Philips announced the company will expand on a previous recall in an ongoing effort to remove equipment that could have a contaminant in one of the plastic components.
PLEASANTON, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced that the company is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results